CLINICAL_TRIALS
trial_result
· 2011-12-23
Clinical Trial Update: A Study of Tadalafil in Men With Benign Prostatic Hyperplasia [Phase 3]
Summary
A Phase 3 study evaluating tadalafil for Benign Prostatic Hyperplasia has completed. Results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Benign Prostatic Hyperplasia (BPH) | Phase 3 | Status: COMPLETED | Results posted: 2011-12-23